← Back to Search

Behavioural Intervention

Contingency Management (CM) for Alcoholism

N/A
Recruiting
Led By Arpan G Patel, MD
Research Sponsored by Arpan A. Patel, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have received a liver transplant
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights

Study Summary

"This trial aims to study the effectiveness of a behavioral treatment called 'contingency management' in patients with Alcohol-Associated Liver Disease (ALD) who have received a liver transplant. ALD is

Who is the study for?
This trial is for adults over 18 who have had a liver transplant and returned to drinking alcohol within the last month. They must be willing to undergo behavioral treatment for their alcohol use disorder and able to follow study procedures.Check my eligibility
What is being tested?
The study tests 'contingency management' (CM), a behavior therapy offering rewards for staying sober, in patients with alcoholic liver disease post-liver transplant. Half will receive CM for 10 weeks; the other half get usual care. All interactions are via Zoom.See study design
What are the potential side effects?
Since CM involves psychological and social interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience stress or anxiety related to adherence to the program's requirements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a liver transplant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Non-Drinking Days
Secondary outcome measures
Client Satisfaction Questionnaire-8.
Patient-Reported Outcomes Measurement Information System (PROMIS® 29+2 Profile v2.1 (PROPr))

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency Management (CM)Experimental Treatment1 Intervention
Study subjects who have received a liver transplant and have been randomized to the treatment arm will receive contingency management, a positive reinforcement behavioral treatment with escalating rewards for consecutive either negative urine and blood tests (or lower value of metabolites than the previous week for PeTH) depending on which results are received first, capped at a maximum of $80 (in the form of a gift card) at the week 10 visit.
Group II: Treatment As Usual (TAU)Active Control1 Intervention
Study Subjects randomized to treatment as usual (TAU) will not receive an intervention. They will continue with follow-up visits in the outpatient clinic as part of standard of care. .
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2014
Completed Phase 2
~3430

Find a Location

Who is running the clinical trial?

Arpan A. Patel, MDLead Sponsor
Arpan G Patel, MDPrincipal InvestigatorUniversity of California, Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction excluding individuals younger than 70 from participating in this study?

"As per the trial's eligibility requirements, individuals aged 18 to 99 are eligible to participate."

Answered by AI

Which individuals meet the criteria for participation in this research study?

"Patients aged between 18 and 99 with a diagnosis of alcohol use disorder are eligible for participation in this trial, which aims to recruit approximately 30 individuals."

Answered by AI

How many individuals are currently enrolled in this clinical study?

"Indeed, the details available on clinicaltrials.gov confirm that this trial is actively seeking candidates. The study was first listed on April 1st, 2024, and underwent its most recent update on April 29th, 2024. A total of 30 participants are sought from a single location."

Answered by AI

Are there ongoing efforts to recruit participants for this clinical trial?

"The details on clinicaltrials.gov demonstrate that this investigation is presently seeking potential participants. The trial was initially listed on April 1st, 2024 and underwent the latest revision on April 29th, 2024. Enrollment for this study aims to recruit a total of 30 individuals from one designated site."

Answered by AI

Who else is applying?

What site did they apply to?
Pfleger Liver Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
CM for Patients With ALD After Liver Transplant
Arpan A. Patel, MD 2024. "CM for Patients With ALD After Liver Transplant". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06304467.
All > Liver Transplant > Paid Studies Ventura
~20 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top